Wize Pharma News
News
0
Ticker
WIZP
ISIN
US97751M2070
Wize Pharma Eulerpool News
Wize Pharma Stock News
Wize Pharma is being monitored by journalists and investors worldwide. We gather the latest Wize Pharma news here.
- February 16·Yahoo
- December 9·businesswire
- November 12·Yahoo
- November 10·businesswire
- October 28·investing
- October 25·The Guardian
- September 30·MarketWatch
- August 2·https://www.thelincolnianonline.com
- May 20·businesswire
- May 7·Yahoo
- April 19·https://www.hpj.com
Wize Pharma Stock Press Releases
Wize Pharma regularly publishes news on the company's website that are relevant for investors.
- March 24•Wize Pharma
- February 16•Wize Pharma
- January 4•Wize Pharma
- December 30•Wize Pharma
- November 12•Wize Pharma
- May 27•Wize Pharma
- May 18•Wize Pharma
- May 7•Wize Pharma
- April 21•Wize Pharma
- February 20•Wize Pharma
- January 21•Wize Pharma
- January 16•Wize Pharma
Wize Pharma News 2026
This page contains all current news, analysis and press releases for Wize Pharma stock (WIZP, ISIN: US97751M2070). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Wize Pharma.
Wize Pharma Stock
Wize Pharma Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases.